Beyond maximally tolerated statins: PCSK9 inhibitors as a critical adjunct for cardiovascular risk reduction in peripheral artery disease-a systematic review and meta-analysis. - Ariyanti D; Rayyan MIR; Shabri HA; Nurwahyudi N; Husniatama MD; Erisadana RN; Larasati S; Mustofa A; Faizah NN; Putranto JNE; Alkaff FF; Saputra PBT (Current medical research and opinion, 2026)